Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report-Reference-Cited by-同舟云学术

Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report

Published:2020-01-20 Issue:2 Volume:26 Page:236-243
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Kim Doyoung,Kobayashi Tetsuro,Voisin Benjamin,Jo Jay-Hyun,Sakamoto Keiko,Jin Seon-Pil,Kelly Michael,Pasieka Helena B.,Naff Jessica L.,Meyerle Jon H.,Ikpeama Ijeoma D.,Fahle Gary A.,Davis Fred P.,Rosenzweig Sergio D.,Alejo Julie C.,Pittaluga Stefania,Kong Heidi H.^ORCID,Freeman Alexandra F.,Nagao Keisuke^ORCID

Funder

National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health

Frederick National Laboratory for Cancer Research

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-019-0733-7.pdf

Reference38 articles.

1. Duong, T. A., Valeyrie-Allanore, L., Wolkenstein, P. & Chosidow, O. Severe cutaneous adverse reactions to drugs. Lancet 390, 1996–2011 (2017).

2. Kano, Y. et al. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). J. Dermatol. 42, 276–282 (2015).